DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 145 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $237,864 | +10.6% | 18,700 | +22.5% | 0.00% | – |
| Q2 2023 | $215,016 | -5.9% | 15,271 | +0.4% | 0.00% | – |
| Q1 2023 | $228,529 | +16.8% | 15,215 | +27.5% | 0.00% | – |
| Q4 2022 | $195,664 | -93.4% | 11,938 | -96.1% | 0.00% | -100.0% |
| Q4 2021 | $2,974,000 | -70.3% | 304,451 | +3.3% | 0.00% | -71.4% |
| Q3 2021 | $10,017,000 | -7.3% | 294,803 | -0.1% | 0.01% | 0.0% |
| Q2 2021 | $10,807,000 | -8.5% | 295,201 | +12.1% | 0.01% | -22.2% |
| Q1 2021 | $11,809,000 | -3.7% | 263,359 | +22.6% | 0.01% | -10.0% |
| Q4 2020 | $12,259,000 | +18.4% | 214,802 | +6.4% | 0.01% | +11.1% |
| Q3 2020 | $10,357,000 | +10.4% | 201,896 | +28.5% | 0.01% | 0.0% |
| Q2 2020 | $9,383,000 | +222.1% | 157,114 | +122.1% | 0.01% | +200.0% |
| Q1 2020 | $2,913,000 | – | 70,748 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 4,104,140 | $93,041,000 | 43.52% |
| SV Health Investors, LLC | 1,716,303 | $38,909,000 | 20.55% |
| PURA VIDA INVESTMENTS, LLC | 68,154 | $1,545,000 | 0.65% |
| Redmile Group, LLC | 683,880 | $14,658,000 | 0.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 77,000 | $1,746,000 | 0.62% |
| SPHERA FUNDS MANAGEMENT LTD. | 224,154 | $5,008,000 | 0.59% |
| EMERALD ADVISERS, LLC | 482,626 | $10,941,000 | 0.42% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 416,342 | $9,438,000 | 0.38% |
| Orbimed Advisors | 1,176,070 | $26,662,000 | 0.34% |
| VIKING GLOBAL INVESTORS LP | 2,394,625 | $54,286,000 | 0.33% |